N-Acetylcysteine is the drug of choice for the treatment of an acetaminophen overdose. It is thought to provide cysteine for glutathione synthesis and possibly to form an adduct directly with the toxic metabolite of acetaminophen, N-acetyl-p-benzoquinoneimine. However, these hypothese have not been tested in vivo, and other mechanisms of action such as reduction of the quinoneimine might be responsible for the clinical efficacy of N-acetylcysteine. After the administration to rats of acetaminophen (1 g/kg) intraduodenally (i.d.) and of [ 35 S]-Nacetylcysteine (1.2 g/kg i.d.), the specific activity of the N-acetylcysteine adduct of acetaminophen (mercapturic acid) isolated from urine and assayed by high pressure liquid chromatography averaged 76±6% of the specific activity of the glutathione-acetaminophen adduct excreted in bile, indicating that virtually all N-acetylcysteine-acetaminophen originated from the metabolism of the glutathione-acetaminophen adduct rather than from a direct reaction with the toxic metabolite. N-Acetylcysteine promptly reversed the acetaminophen-induced depletion of glutathione by increasing glutathione synthesis from 0.54 to 2.69 µmol/g per h. Exogenous N-acetylcysteine did not increase the formation of the N-acetylcysteine and glutathione adducts of acetaminophen in fed rats. However, when rats were fasted before the administration of acetaminophen, thereby increasing the stress on the glutathione pool, exogenous N-acetylcysteine significantly increased the formation of the acetaminophen-glutathione adduct from 57 to 105 nmol/min per 100 g. g/kg i.d.), the specific activity of the N-acetylcysteine adduct of acetaminophen (mercapturic acid) isolated from urine and assayed by high pressure liquid chromatography averaged 76±6% of the specific activity of the glutathione-acetaminophen adduct excreted in bile, indicating that virtually all N-acetylcysteineacetaminophen originated from the metabolism of the glutathione-acetaminophen adduct rather than from a direct reaction with the toxic metabolite. N-Acetylcysteine promptly reversed the acetaminophen-induced depletion of glutathione by increasing gluta- 
g/kg i.d.), the specific activity of the N-acetylcysteine adduct of acetaminophen (mercapturic acid) isolated from urine and assayed by high pressure liquid chromatography averaged 76±6% of the specific activity of the glutathione-acetaminophen adduct excreted in bile, indicating that virtually all N-acetylcysteineacetaminophen originated from the metabolism of the glutathione-acetaminophen adduct rather than from a direct reaction with the toxic metabolite. N-Acetylcysteine promptly reversed the acetaminophen-induced depletion of glutathione by increasing glutathione synthesis from 0.54 to 2.69 gmol/g per h. Ex- ogenous N-acetylcysteine did not increase the formation of the N-acetylcysteine and glutathione adducts of acetaminophen in fed rats. However, when rats were fasted before the administration of acetaminophen, thereby increasing the stress on the glutathione pool, exogenous N-acetylcysteine significantly increased the formation of the acetaminophen-glutathione adduct from 57 to 105 nmol/min per 100 g. Although the excretion of acetaminophen sulfate increased from 85±15 to 211±17 iimol/100 g per 24 h after N-acetylcysteine, kinetic simulations showed that increased sulfation does not significantly decrease formation of the toxic metabolite. Reduction of the benzoquinoneimine by N-acetylcysteine should result in the formation of Nacetylcysteine disulfides and glutathione disulfide via thiol-disulfide exchange. Acetaminophen alone depleted intracellular glutathione, and led to a progressive decrease in the biliary excretion of glutathione and glutathione disulfide. N-Acetylcysteine alone did not affect the biliary excretion of glutathione disulfide. However, when administered after acetaminophen, Nacetylcysteine produced a marked increase in the biliary excretion of glutathione disulfide from 1.2±0.3 nmol/min per 100 g in control animals to 5.7±0.8 nmol/min per 100 g. Animals treated with acetaminophen and N-acetylcysteine excreted 2.7±0.8 nmol/ min per 100 g of N-acetylcysteine disulfides (measured by high performance liquid chromatography) compared to 0.4±0.1 nmol/min per 100 g in rats treated with N-acetylcysteine alone. In conclusion, exogenous N-acetylcysteine does not form significant amounts of conjugate with the reactive metabolite of acetaminophen in the rat in vivo but increases glutathione synthesis, thus providing more substrate for the detoxification of the reactive metabolite in the early phase of an acetaminophen intoxication when the critical reaction with vital macromolecules occurs.
totoxicitv of acetaminophen both in animal models (1) (2) (3) (4) and clinical practice (a, 6). Because of its ease of administration and low toxicity, N-acetylcvsteine is currently the favorite compound for the treatment of acetaminophen overdose in man (6, 7) . Despite its widespread clinical use, however, the mechanism(s) of action of N-acetvlcvsteine in vivo remain to be (1em-onstrated. N-Acetvlcvsteine could conceivably protect against the hepatotoxicity of acetaminophen in several ways. First, N-acetvlcvsteine ma) serve as a precursor for glutathione synthesis. Glutathione plays a critical role in the protection against hepatic necrosis produced by acetaminophen (1) . Hepatocellular necrosis occurs only when the hepatic content of glutathione falls below a critical threshold concentration (1) . A stimulation of glutathione synthesis following the administration of N-acetylcysteine and thus a greater availability of glutathione for the detoxification of the toxic acetaminophen intermediate should protect against liver injury. In isolated hepatocytes, N-acetylcysteine is indeed capable of supporting glutathione synthesis when it is the only source of cysteine (8) . However, in isolated cells incubated with acetaminophen, very high concentrations of N-acetylcysteine or preincubation with the sulfhvdrvl are required to increase the formation of acetaminophen-glutathione (9) . Our recent studies of glutathione kinetics following a toxic dose of acetaminophen further questioned the importance of this mechanism of action (10) . The synthesis of glutathione following a large dose of acetaminophen was found to be suppressed, rather than stimulated, as one would expect from a depletion of hepatic glutathione (11) . Furthermore, some investigators have reported that N-acetylcysteine does not prevent the acetaminophen-induced depletion of glutathione suggesting that the antidote does not support glutathione synthesis in vivo (12) .
A second potential mechanism of action is direct adduct formation between N-acetylcysteine and the reactive intermediate of acetaminophen, thereby preventing covalent binding and cell injurv. In microsomal incubations, the reactive metabolite of acetaminophen indeed readily forms adducts with a variety of sulfhvdrvl anions including the Nacetylcysteine anion (13) . However, the incubation of isolated mouse hiepatocytes with acetaminophen and N-acetyslcsteine does not result in the formation of the N-acetvlcvsteine adduct of acetaminiophen (8, 9) . In vivo, the administration of N-acetylcysteine only moderately increases the formation of the N-acetvlcysteine adduct of acetamiinophen (mercapturic acid) in overdosed patients (14) and mice (4, 15) . Thus it is not clear whether direct adduct forijiation is an important protective mechanism ill vivo.
As a third possibility, N-acetylcysteine might protect by increasing the availability of inorganic sulfate, thus increasing the formation of acetaminophen-sulfate and simultaneously decreasing the fraction of acetamninophen metabolized to the toxic intermiediate (16 (17) .
From data obtained mostly in vitro, therefore, a number of potential mechanisms of action of N-acetvleysteine have been demonstrated. However, these mechanistic studies have not evaluated the importance of the potential interactions of N-acetylcvsteine with the toxic process in vivo. To elucidate the mechanism of action in vivo, we have administered radioactively labeled N-acetvlcysteine together with acetaminophen to rats to determine the contribution of exogenous Nacetyrlcsteine to the formation of the N-acetylcvsteine alduct of acetaminophen ( (15, 19) .
In order to test the hypothesis that N-acetylcysteine protects in vivo by reducing the metabolite N-acetyl-p-benzoquinoneimine back to acetaminophen, we measured the bil- (23) . Glutathione disulfide was measured by the same method following derivatization of reduced glutathione with 2-vinylpyridine (24) . The addition of N-acetylcysteine to bile samples showed that N-acetylcysteine does not interfere with the enzymatic glutathione assay.
In similarly prepared animals, the biliary excretion of Nacetylcysteine and N,N'-diacetylcystine was measured between 30 and 45 min following the administration of 1.2 g/ kg of N-acetylcysteine. In these experiments, the control group received saline instead of 1 g/kg of acetaminophen 80 min before the antidote. An additional control group again received 1 ml/kg of diethyl maleate prior to N-acetylcysteine.
N-Acetylcysteine in bile was assayed as the mixed disulfide with thionitrobenzoic acid by high pressure liquid chromatography by a modification of the assay described by Reeve et al. (25) with DL-penicillamine as internal standard (Fig. 1) . To (23) .
To study the incorporation of [35S]-N-acetylcysteine into metabolites of acetaminophen rats were kept in metabolic cages for 24 h after administration of 1 g/kg of acetaminophen (30 mg/ml) followed 30 min later by 1.2 g/kg of [5S]-N-acetylcysteine (120 mg/ml) by gavage. Because fed rats are relatively resistant to the hepatotoxic effects of acetaminophen, the animals were fasted for 48 h before the study in order to demonstrate a protective effect of N-acetylcysteine. Control animals received 0.9% saline instead of N-acetylcysteine. After 24 h, portions of the liver were processed for light microscopy (27) or homogenized in 9 vol of 0.1 M phosphate buffer, pH 7.4, containing 5 mM EDTA for measurement of nonprotein sulfhydryls by the method of Ellman (28) .
The metabolites of acetaminophen in the urine of the rats kept in metabolic cages were quantitated with the sodium acetate/methanol high pressure liquid chromatography system described above and p-fluorophenol as internal standard. The necrosis was graded as 0 = absent, 1+ necrosis = <6% of hepatocytes necrotic, 2+ = 6-25%, 3+ = 26-50% and 4+ = >50% of the hepatocytes necrotic as previously described (27) . All data are expressed as mean±SE. The Wilcoxon rank sum test was used for statistical analysis. Table I , only a very small fraction of the administered N-acetylcysteine appeared in the glutathione adduct and the N-acetylcysteine adduct of acetaminophen (mercapturic acid) during the first few hours after the toxic dose of acetaminophen when hepatic gluthathione depletion was at its maximum. In rats without biliary fistula, most of the glutathione adduct excreted in bile would eventually appear as the N-acetylcysteine adduct (mercapturic acid) in urine. The 2.73% of the administered dose of acetylcysteine excreted in the urine in 24 h as the mercapturic acid thus represent the sum of the adduct formed with glutathione and possibly with N-acetylcysteine directly. Both in the early hours and for the entire 24-h collection, the fractional incorporation of N-acetylcysteine into acetaminophen-sulfate or excreted free as N-ace- If the administered N-acetylcysteine served as a nucleophile itself in vivo and thus formed an adduct directly with the electrophilic metabolite of acetaminophen, the specific activity of the mercapturic acid excreted in urine would be expected to approach the specific activity of the administered N-acetylcysteine. Moreover, the specific activity also would be expected to exceed the specific activity of the glutathione adduct appearing in bile at least initially when the specific activity of the intrahepatic N-acetylcysteine must exceed the specific activity of the intrahepatic glutathione. However, the specific activity of the acetaminophen mercapturic acid amounted to only 3.35±0.98 (n = 5), 10.94±0.43, and 17.98±0.84% of the specific activity of the administered N-acetylcysteine during the first, second, and third hour after the administration of N-acetylcysteine. Furthermore, the specific activity of the acetaminophen mercapturic acid in urine was lower than the specific activity of the glutathione adduct in bile (Fig. 2) . This indicates that virtually all of the labeled mercapturic acid in urine originated from labeled acetaminophen-gluta- thione rather than from a direct reaction of N-acetylcysteine with the toxic metabolite.
RESULTS

As shown in
To test the hypothesis that N-acetylcysteine reduces the reactive intermediate of acetaminophen back to acetaminophen and in the process increases the formation of disulfides, we measured the biliary excretion of glutathione and N-acetylcysteine disulfides. Increased intracellular concentrations of disulfides result in an increased formation of glutathione disulfide by thiol-disulfide exchange mediated by thiol transferases and a constant fraction of the thus generated glutathione disulfide will be released by the cell (29) . As shown in Fig. 3 , the administration of acetaminophen led to a progressive decrease in the biliary excretion of glutathione disulfide. The biliary excretion of glutathione (Fig. 4 ) decreased in parallel, reflecting the progressive intracellular depletion of glutathione. NAcetylcysteine alone did not affect the biliary excretion of glutathione disulfide. However, when the same dose of N-acetylcysteine was administered 80 min after 1 g/kg of acetaminophen, the biliary excretion of glutathione disulfide increased. promptly (Fig. 3) . When N-acetylcysteine was administered to rats pretreated with diethyl maleate instead of acetaminophen, the biliary excretion of glutathione disulfide remained low although the hepatic concentration of glutathione increased from 0.43±0.02 to 4.38±0.43 ,mol/ g and the biliary excretion of reduced glutathione was not significantly different from the animals that had received acetaminophen prior to the N-acetylcysteine. The possibility was further examined that the increased biliary excretion of glutathione disulfide after acetaminophen plus N-acetylcysteine, but not after acetaminophen alone, nor after diethyl maleate plus N-acetylcysteine, resulted from thiol-disulfide exchange with the N-acetylcysteine disulfides formed during reduction of the reactive intermediate of acet- aminophen. Rats treated with acetaminophen and Nacetylcysteine excreted significantly more N-acetylcysteine disulfides in bile (2.68±0.75 nmol/min per 100 g, n = 4) than rats treated with N-acetylcysteine alone (0.43±0.11 nmol/min per 100 g, n = 7) and animals treated with diethyl maleate and N-acetylcysteine (0.14±0.02 nmol/min per 100 g). Because figure) . The that only the initial phase of the study could be evalethvl maleate-uated. In contrast to the fed rats where N-acetylvere not signif-cvsteine treatment did not significantly increase the istrattion of biliary excretion of acetaminophen-glutathione adduct compared to saline-treated controls, the antidote significantly increased the biliary excretion of acetaminophen-glutathione in the fasted animals (Table II) . re with small This early increase in the partial clearance by the glutathione-mercapturic acid pathway in fasted animals ninophen-glu-was not apparent in the 24-h urine collections, alte pool with though the administration of the antidote markedly centration of increased the formation of acetaminophen sulfate with of acetamin-a concomitant decrease in acetaminophen glucuronide are shown in (Table I1I ). The intrahepatic concentration of gluta-)hen depleted thione 24 
Simulations
To estimate the effect of an increased availability of sulfate on the formation of the various metabolites of acetaminophen, the generation of the metabolites was simulated using the kinetic model shown in Fig.  7 . Estimates of the rate constants for the formation of each metabolite were based on the data of Price and Jollow (30) . In one model, glucuronidation was assumed to follow first-order kinetics (20) . In a second model, glucuronidation was assumed to be capacity limited and parameter estimates were based on data of Galinsky and Levy (31 simulations, the value for the apparent maximal rate of sulfation, VmaxI was therefore gradually increased to reflect an increased availability of sulfate while keeping all other parameters constant. The set of differential equations was integrated using the program INTDIFF of PROPHET (32). The model predicts that within 24 h, 48% of a dose of 1 g/kg of acetaminophen will be metabolized to the glucuronide, 11% to the sulfate and 5% to the reactive metabolite, most of which will appear as the N-acetylcysteine adduct, whereas 22% will be eliminated as free acetaminophen and 14% will not have been metabolized as yet (Fig.  8a) . Comparable percentages are obtained when glucuronidation is assumed to be capacity limited (Fig.  8b) . Similar fractions of administered dose would be expected to appear in urine over the same period of time, and both models are thus quite consistent with our experimentally determined data (Table 1II ). With increasing availability of sulfate (reflected by Vmax in the model), the formation of acetaminophen-sulfate increases. As expected, the formation of the other metabolites decreases concomitantly (Fig. 8) . Although the generation and renal elimination of metabolites formed by first-order processes decreases proportionally, increased sulfation has little effect on the absolute amounts of metabolites formed via relatively minor pathways. Thus, doubling the maximal rate of sulfation decreases the formation of the reactive metabolite only from 5.4 to 5.0% (Fig. 8a) and from 6.1 to 5.6% (Fig. 8b) of the administered dose in the two models, a reduction that is not meaningful toxicologically. DISCUSSION N-Acetylcysteine is an effective antidote against liver injury produced by acetarninophen in animal models (3, 4, 33) All animals were fasted for 48 h and received 1 gikg of acetaminophen per os. XN-Acetvlcvsteine, 1.2 g/kg, was administered per os 30 min after 1 g/kg of acetaminophen.
acetylcysteine seemingly confirms the rationale of the therapeutic intervention with sulfhydryls, which were thought to promote glutathione synthesis or to form direct adducts with the reactive intermediate of acetaminophen (1, 2). In microsomal incubations lacking glutathione and glutathione transferases, N-acetylcysteine forms an adduct with the reactive metabolite of acetaminophen (13) . The protective effect of N-acetylcysteine in vivo might thus conceivably be due to direct conjugation, although no adduct formation has been observed in isolated mouse hepatocytes (8, 9) . However, it is evident from our data that the specific activity of the glutathione adduct exceeded the specific activity of the mercapturic acid at all times, indicating that most of the labeled mercapturic acid originated from labeled glutathione. The small differences in the specific activities between the glutathione adduct and the mer- FiCLT:RE 7 Kinetic model and kinetic parameters used to simulate the effect of an increased availability of sulfate on the metabolism of acetaminophen. Estimates of the rate constants for the formation of each metabolite and the rate of urinary excretion of acetaminophen are based on published data (30) . The formation of the glucuronide was alternatively assumed to be first-order (k1 = 0.045 h-') or capacity-limited (V%,, 192 Amol/kg per h, k,,, 2.7 mmol/,kg) (31). The rate constant for the formation of the reactive intermediate, k2, was assumed to be 0.005 h', and the constant for renal elimination of acetaminophen k,3 = 0.02 h-. lncreasing the availability of sulfate will increase sulfation in a maniser consistent with NMichaelis-Menten kinetics. The Vlma, was assumed to be 50 4mol/kg per h in the basal state and was gradually increased to simulate an increased availability of sulfate. k,. = 2.15 mmol/kg. capturic acid are probably due to the delay in the appearance of mercapturic acid in urine compared to the appearance of the glutathione adduct in bile. The comparison of the specific activities of the administered N-acetylcysteine and the mercapturic acid of acetaminophen appearing in urine also supports the conclusion that most of the labeled mercapturic acid originated from the glutathione adduct. Even shortly after the administration of the antidote, when the total body pool of N-acetylcysteine must have the same specific activity as the administered N-acetylcysteine, the specific activity of the mercapturic acid still amounted to only 3-18% of the specific activity of the administered N-acetylcysteine. At a time when the specific activity of the hepatic glutathione pool is still low, the specific activity of the mercapturic acid in urine should approach the specific activity of the administered N-acetylcysteine if substantial direct conjugation of the reactive intermediate of acetaminophen with N-acetyleysteine occurs. At a later time, the specific activity of the glutathione pool (and thus of the mercapturic acid excreted in urine) would be expected to approach the specific activity of the administered Nacetylcysteine because the amount of cysteine liberated from N-acetylcysteine used for glutathione synthesis is so large compared to the endogenous free cysteine pool. This explains why -20 of the 30 timol of acetaminophen-mercapturic acid excreted in 24 h contained cysteine originating from the administered Nacetylcysteine.
The administration of 1 g/kg of acetaminophen leads to a rapid depletion of hepatic glutathione that reaches a nadir within 1 h. Because glutathione synthesis is regulated by a feedback mechanism (34, 35), this depletion should markedly stimulate glutathione synthesis and thus, increase the requirement for glutathione precursors. As the rate of glutathione synthesis is stimulated, the availability of cysteine, which is preseist in much lower concentrations than glycine or glutamic acid, may become the rate-limiting step in glutathione synthesis (36 (11) . In our studies, the hepatic synthesis of glutathione promptly increased after Nacetylcysteine administration. The kinetic data are supported by the observation that the hepatic concentration of glutathione markedly increased after Nacetylcysteine, whereas the loss of glutathione via adduct formation remained unchanged. N-Acetylcysteine has also been shown to prevent acetaminophen-induced depletion of hepatic glutathione in the mouse (37) . This effect was attributed to delayed gastric emptying of acetaminophen resulting in decreased absorption of acetaminophen (37) . Such a mechanism can clearly not account for our data because the drug was administered intraduodenally, and the biliary excretion of acetaminophen-glutathione in N-acetylcysteine-treated and control animals was either the same in fed rats or even increased in fasted animals.
In the face of an increased hepatic concentration of (14) . In these studies, however, more acetaminophen was recovered from the patients treated with N-acetylcysteine, suggesting that these patients ingested a larger dose of the analgesic, which would explain the increase in acetaminophenmercapturate. The extent of cell damage presents a major problem in interpreting data on the formation of metabolites, not only in vitro, but also in vivo, particularly when dealing with models that are very sensitive to the hepatotoxic effect of acetaminophen. Dead cells will no longer be metabolically active. Thus, if N-acetylcysteine by maintaining cell viability, results in the formation of more glucuronide, sulfate and sulfhydryl conjugates (8) , its protective effect is not necessarily causally related to an increased conjugation of acetaminophen.
The observation that N-acetylcysteine and acetaminophen, but neither of the compounds alone, increase the biliary excretion of glutathione disulfide suggests that N-acetylcysteine, in addition to increasing glutathione synthesis, reduces a metabolite of acetamninophen. N-acetylcysteine did not increase the biliary excretion of disulfides in animals pretreated with diethyl maleate in order to deplete glutathione to a similar degree, as in acetaminophen-treated animals. This indicates a specific interaction of the antidote with a product of acetaminophen metabolism. In vitro, sulfhydryls as well as ascorbic acid reduce the ultimate toxic metabolite of acetaminophen, N-acetyl-p-benzoquinoneimine back to acetaminophen (17, 38) , and it is likely that a similar reduction of the benzoquinoneimine occurs with N-acetylcysteine in vivo. Indeed, the biliary excretion of N-acetylcysteine disulfides was significantly higher in animals pretreated with acetaminophen. Although a similar reduction should theoretically occur with glutathione, the presence of glutathione transferases in vivo will strongly favor the formation of the glutathione adduct of Nacetyl-p-benzoquinoneimine, i.e., acetaminophen-glutathione, rather than the reductive pathway (17, 39) . The quantitative importance of this detoxification pathway cannot be readily assessed. Because of intracellular thiol-disulfide exchange and effective reduction of glutathione disulfide by glutathione reductase, only a small fraction of the generated disulfides will be excreted in bile (40, 41) but the measured increment in biliary disulfides could well account for the decrease in covalent binding of acetaminophen that is associated with the protection by N-acetylcysteine (42) . If the reductive mechanism contributed significantly to the protective effect of N-acetylcysteine one would expect a decreased formation of the glutathione adduct that clearly did not occur. On the other hand, the decrease in the intracellular thiol/disulfide ratio resulting from the reductive pathway will not only lead to an increased formation of glutathione disulfide but also to an increased formation of protein-mixed disulfides that could protect nucleophilic sites on proteins from the electrophilic intermediate of acetaminophen. Further studies will have to assess the quantitative significance of the reductive pathway.
Approximately five times more of the administered radioactivity ended up in the sulfate fraction than in the N-acetylcysteine adduct (mercapturic acid) and the excretion of acetaminophen-sulfate markedly increased following N-acetylcysteine. The increased partial clearance of acetaminophen via the sulfation pathway would be expected to decrease the fraction of the administered dose passing through the toxifying pathway and may account for the minimal shortening of the half-life observed after relatively low doses of acetaminophen and N-acetylcysteine (16) . Increased sulfation has, therefore, been proposed to be a possible mechanism of action of N-acetylcysteine in preventing the hepatotoxicity of acetaminophen (16) . Although high doses of sodium sulfate decrease the mortality from large doses of acetaminophen in mice, we have not been able to demonstrate an actual protective effect against the hepatotoxicity of acetaminophen (Lauterburg and Mitchell, unpublished data). The reason for the lack of a hepatoprotective effect of an increased availability of sulfate becomes evident from our simulation studies. Doubling or even tripling the formation of acetaminophen-sulfate slightly increases the rate of disappearance of acetaminophen but minimally decreases the fraction of a dose of acetaminophen metabolized to the reactive metabolite (Fig. 8) . That N-acetylcysteine does not protect by increasing the sulfation of acetaminophen is supported by studies in mice where N-acetylcysteine prevents acetaminophen-induced hepatic necrosis without increasing the formation of acetaminophen-sulfate (15) .
In conclusion, our data demonstrate that exogenous N-acetylcysteine does not form significant amounts of conjugate with the reactive metabolite of acetaminophen in the rat in vivo. The antidote provides a source of sulfate, thus stimulating the partial clearance of acetaminophen by the nontoxic sulfation pathway. Our data, in addition, demonstrate that N-acetylcysteine reduces the reactive intermediate, N-acetylp-benzoquinoneimine, back to acetaminophen in vivo, although the quantitative significance of this pathway for protection is yet to be determined. Most imporMechanism of Action of N-Acetylcysteine in Acetaminophen Hepatotoxicitytantly, however, N-acetylcysteine markedly increases the synthesis of glutathione following a large dose of acetaminophen, thus providing more substrate for the detoxification of the reactive metabolite by adduct formation during the short period of time when the critical cell injury occurs.
